You are here:
Safe and effective human papillomavirus vaccines offer protection against 70% of all cervical cancer cases.
Gavi supports inactivated polio vaccine as part of routine immunisation programmes.
Gavi funds Japanese encephalitis catch-up campaigns. Countries then self-finance the vaccine for routine immunisation.
Gavi helps to combat measles through four types of vaccine support: measles second dose, measles-rubella, measles campaigns and outbreak responses.
The Gavi-funded measles-rubella vaccine provides a 2-in-1 shot against two devastating diseases.
Gavi-supported campaigns have reached more than 220 million people.
Gavi helps to prevent cholera outbreaks through its support to the global oral cholera vaccine stockpile.
With Gavi support, pentavalent vaccine is available in the 73 poorest countries in the world.
Gavi’s 2015 target of 45 pneumococcal introductions achieved more than one year ahead of schedule.
Gavi supports developing countries to introduce rotavirus vaccines, protecting against severe and deadly diarrhoea.
Gavi provides yellow fever support for routine immunisation, campaigns in high-risk countries and emergency stockpiles in case of outbreaks.
Since the first human papillomavirus (HPV) vaccine demonstration project in Kenya in 2013, an estimated 1 million girls have been vaccinated with Gavi support – a figure expected to rise to 30 million by the end of 2020. Gavi has already started to fund national HPV programmes in Rwanda and Uganda.
Concerned about the misuse of Gavi resources? Report it now.
© Gavi 2016
modal window here